Pharma & Biotech
Canaccord Genuity Corp, on behalf of a syndicate of underwriters, agreed to purchase 29 million units in...
AgraFlora Organics intends to be a top cannabis player in Canada and Europe
Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre
The Valens Company: A global cannabis group, scaling up, and just beginning to show what it was 'made to do'
Only registered members can use this feature.
Copyright © Proactive Investors 2021.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.